Invest in your health.

A Physician’s Guide to Using CGM to Detect Early Signs of Insulin Resistance

Picture of Michael Leone, MD

Michael Leone, MD

blog post

Estimated read time: 7 min

Summary:

  • The 1-hour post-prandial peak is a metric of insulin resistance, as consistently exceeding 155 mg/dL often predicts future diabetes risk even when your fasting lab results look normal.
  • A healthy post-prandial return-to-baseline occurs within 2 to 4 hours, serving as a real-time measure of how efficiently your muscles are clearing sugar from your blood.
  • Real-time biofeedback identifies your personal triggers, showing exactly how factors like poor sleep, acute stress, and post-meal movement impact your unique metabolic health.

Introduction

For decades, medicine viewed metabolic health through a very narrow lens. You would visit your doctor once a year, have your blood drawn after fasting for twelve hours, and receive a single number: your fasting glucose. If it was under 100 mg/dL, you were told you were “healthy.” If it was over 126 mg/dL, you had “diabetes.”

But there is a massive, invisible “gray zone” between those numbers. Relying on a once-a-year fasting test is like trying to understand a movie by looking at a single still frame at the ten-minute mark. You miss the plot, the action, and the early warning signs that the story might be headed for a crash. We are essentially checking the engine oil only when the car is parked in the garage, rather than seeing how it performs at 70 miles per hour on the highway.

Today, we have the metabolic equivalent of a high-definition, 24/7 dashboard camera: the Continuous Glucose Monitor, or CGM. Originally designed as a life-saving tool for type 1 diabetes, these small, wearable sensors—now increasingly available over-the-counter—allow us to move beyond the “snapshot” and into real-time biofeedback. For healthy adults, this technology isn’t just for managing a disease; it’s a tool for early detection of insulin resistance and personalized lifestyle design to counteract metabolic disease.

As a physician, I believe the true value of CGM in healthy people lies in its ability to flag the “silent slide” toward insulin resistance before your fasting glucose or A1c look abnormal. Here is how you can use this data to take control of your metabolic future.

The New Standards of “Normal”

Before you can optimize your metabolic health, you need to know where the goalposts are. Large-scale studies on healthy, non-diabetic adults have given us a better picture of what a high-functioning metabolism looks like.

In general, a healthy adult maintains an average glucose between 98 and 99 mg/dL throughout the day.[1,2] While your sugar will naturally rise after you eat, a resilient body spends about 96% of the day—nearly 23 hours—within the “safe zone” of 70 to 140 mg/dL.[1,2]

However, “normal” is a moving target. Research shows that as we age, our average glucose naturally drifts upward. Individuals over the age of 60 often see an average closer to 104 mg/dL, reflecting a natural, age-related shift in insulin sensitivity.[1,4] Furthermore, sex plays a role; young men (ages 18–26) tend to exhibit slightly higher mean sensor glucose and more frequent daily spikes above 140 mg/dL compared to women of the same age.[4]

While the “average” is a helpful baseline to go off of, it doesn’t tell the whole story. To dive deeper into early insulin resistance detection, we have to look at how the body handles a challenge. This brings us to two specific, advanced metrics: the Post-Prandial Peak and the Return-to-Baseline Time.

The “1-Hour Red Flag”: Why the Peak Matters

In a healthy person, the “peak” glucose level after a meal usually occurs about 45 to 60 minutes after eating and rarely crosses above 140 mg/dL.[1,3] If your sugar consistently spikes above 155 mg/dL at the one-hour mark—even if it returns to a “normal” level by hour two—this might constitute a metabolic “red flag.”[5,7]

Why is this one-hour window worth paying attention to? Because a high one-hour peak is often the very first sign of insulin resistance which is a complex multi-organ pathology that just means your body isn’t processing energy (ie. the glucose you consumed in your meal) as effectively and efficiently as it should be. In fact, individuals with a one-hour glucose level above 155 mg/dL have a four-fold increased risk of developing type 2 diabetes later in life, even if their fasting glucose and HbA1c are currently perfect.[7]

The Return-to-Baseline Metric

Like Post-Prandial-Peak, Return-to-Baseline is another less common metric that can be used to detect early signs of insulin resistance. In a metabolically flexible person, glucose should return to pre-meal levels within 2 to 4 hours.[1,3] If your sugar stays elevated for 4 or 5 hours after a standard meal, it suggests that your body is becoming resistant to insulin.[9,10]

This delayed recovery is often the hallmark of skeletal muscle insulin resistance, which is sometimes referred to as the primary driver of metabolic aging. By watching how long it takes your body to “clear” a meal, you can see exactly how efficient your muscles are at processing fuel. If the sugar lingers, the “sponges” are full or the “faucets” (the insulin receptors) are clogged.[9]

Using Biofeedback to Decode Your Lifestyle

The magic of a CGM isn’t just the data; it’s the context. It connects the dots between your choices and your biology in a way that feels personal and undeniable. We focus on “The Big Four” factors that drive these glucose curves.

1. The Composition of Your Plate

We know that refined grains and liquid sugars cause the fastest, highest peaks. But the CGM reveals the “buffer effect.” When you pair a carbohydrate with fiber, protein, or healthy fats, you effectively slow down the “leak” of sugar into your bloodstream. A carb-to-fiber ratio above 9:1 is a common threshold where we start to see significantly more “time above range.”[12]Interestingly, the order in which you eat your food matters too. Eating your fiber (vegetables) and protein before your starch can significantly flatten the post-prandial peak, as the fiber creates a physical barrier in the gut that slows glucose absorption.

2. The Power of “The Post-Meal Walk”

Your muscles are most “hungry” for glucose immediately after you eat. Studies show that even a short, light walk after a meal can significantly flatten your peak and speed up your return to baseline.[2,11] The CGM provides the instant “proof” that movement is medicine. Even 10 minutes of light movement can produce a visible “dip” in a rising glucose curve.

3. The Hidden Impact of Sleep

Poor sleep is a metabolic thief. When you are sleep-deprived, your body produces more cortisol, which makes you temporarily more insulin resistant. You might notice that after a 5-hour night of sleep, the exact same bowl of oatmeal that usually keeps you stable now causes a massive spike and a slow recovery.[11,13]

4. Circadian Rhythms and Meal Timing

Your body follows a biological clock. Most people are more insulin sensitive in the morning and naturally more resistant in the evening.[4] This means a “late-night pasta dinner” will almost always result in a higher peak and a more delayed return to baseline than the same meal eaten at noon.[4] Your body is simply less equipped to handle a heavy energy load as it prepares for sleep.

Running Your Own 14-Day Experiment

If you are ready to experiment with a CGM, I recommend a structured 14-day protocol to get the most out of the experience.

  1. Baseline Week: Eat and move exactly as you normally do. Don’t try to “fix” your numbers yet. This reveals your current metabolic reality.
  2. Experiment Week: Pick one variable to test each day. Try “The Walk Test” (walking after dinner) one day, and “The Naked Carb Test” (eating fruit alone vs. with Greek yogurt) the next.
  3. Look for Patterns, Not Single Datapoints: Accuracy can vary by 10-15%.[15] Don’t stress about a single reading of 142 vs 138. Look for the average curve of your days over a two-week period.[5]
  4. Mind Your Mental Health: If you find yourself checking the app 50 times a day or feeling anxious about a piece of birthday cake, take the sensor off. The goal is empowerment, not obsession.[15]

The Reality Check: Accuracy and Limitations

While CGMs are revolutionary, we must acknowledge their limits. They measure interstitial fluid (the fluid between your cells), not your blood directly. This means there is a “lag time” of about 5–15 minutes between what is happening in your veins and what shows up on your phone.

Furthermore, device accuracy can be affected by simple things like dehydration or “compression lows” (if you sleep on the sensor at night, the pressure can cause a false low reading). This is why we never use CGM data in isolation to make a medical diagnosis.

The Path Toward Prevention

The Endocrine Society and the American Diabetes Association are beginning to recognize the role of technology in primary prevention.[10] While we are still waiting for 20-year studies to prove that CGM prevents heart attacks, the short-term evidence is compelling: people who use CGMs tend to make better dietary choices, lose more weight, and feel more in control of their health.[11,13]

The era of “one-size-fits-all” nutrition is over. We now know that two people can eat the exact same banana and have completely different metabolic responses. CGM allows us to recognize patterns of early insulin resistance and implement personalized behavioral changes to help prevent progression of the disease.

By identifying an elevated 1-hour post-prandial peak or a delayed return to baseline in your 30s or 40s, you might gain the opportunity to make small but over the long-run, powerful, shifts—more fiber, better sleep, post-meal walks—that we believe can change your health trajectory for the better.

References

  1. Freckmann G, Schauer S, Beltzer A, et al. Continuous glucose profiles in healthy people with fixed meal times and under everyday life conditions. J Diabetes Sci Technol. 2024;18(2):407-413.
  2. DuBose SN, Li Z, Sherr JL, et al. Effect of exercise and meals on continuous glucose monitor data in healthy individuals without diabetes. J Diabetes Sci Technol. 2021;15(3):593-599.
  3. Horton ES. Defining the role of basal and prandial insulin for optimal glycemic control. J Am Coll Cardiol. 2009;53(5 Suppl):S21-S27.
  4. Calvo-Malvar M, Lado-Baleato Ó, Ríos AC, et al. Age, sex, BMI, meal timing, and glycemic response to meal glycemic load. JAMA Netw Open. 2025;8(9):e2533193.
  5. Bergenstal RM, Martens TW, Beck RW. Continuous glucose monitoring. JAMA. 2025;334(24):2220-2222.
  6. Marini MA, Succurro E, Frontoni S, et al. Insulin sensitivity, $\beta$-cell function, and incretin effect in individuals with elevated 1-hour postload plasma glucose levels. Diabetes Care. 2012;35(4):868-872.
  7. Fiorentino TV, Marini MA, Andreozzi F, et al. One-hour postload hyperglycemia is a stronger predictor of type 2 diabetes than impaired fasting glucose. J Clin Endocrinol Metab. 2015;100(10):3744-3751.
  8. Nie Q, Jin X, Mu Y, et al. Insulin resistance and $\beta$-cell dysfunction in individuals with normal glucose tolerance but elevated 1-h post-load plasma glucose. Front Endocrinol. 2025;16:1507107.
  9. Bock G, Dalla Man C, Campioni M, et al. Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance. Diabetes. 2006;55(12):3536-3549.
  10. Rosenzweig JL, Bakris GL, Berglund LF, et al. Primary prevention of ASCVD and T2DM in patients at metabolic risk: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2019;104(9):3939-3985.
  11. Yao J, Brugger VK, Edney SM, et al. Diet, physical activity, and sleep in relation to postprandial glucose responses under free-living conditions: an intensive longitudinal observational study. Int J Behav Nutr Phys Act. 2024;21(1):142.
  12. Bakhshi B, Sultana N, Lin H, et al. Associations of diet composition and quality with continuous glucose monitor-derived glycemic metrics in a community-based cohort. Am J Clin Nutr. 2025;S0002-9165(25)00443-5.
  13. Bermingham KM, Smith HA, Duncan EL, et al. Associations of continuous glucose monitor derived time in range and glycaemic variability with diet lifestyle and demographics. Nat Commun. 2026;10.1038/s41467-026-70308-3.
  14. Vazquez L, Arreola EV, Nagul M, et al. Comparing surrogate indexes for insulin resistance as predictors of type 2 diabetes (T2D). J Clin Endocrinol Metab. 2026;dgag101.
  15. Fellinger E, Brandt T, Creutzburg J, et al. Analytical performance of the FreeStyle Libre 2 glucose sensor in healthy male adults. Sensors (Basel). 2024;24(17):5769.

more insights

blog post

Wearable Health Data: Improving Outcomes with Physician Guidance

Summary:

Wearables become far more powerful when physicians interpret the data, turning raw numbers—like resting heart rate, steps, and sleep time—into meaningful, personalized guidance.

Long‑term trends from wearables help clinicians detect early changes in stress, recovery, sleep, and cardiovascular health, enabling more proactive and preventive care.

Patients achieve better outcomes when wearable data is paired with expert coaching, with studies showing improved activity, sleep habits, and engagement compared to using devices alone.

Read more >
blog post

Before You Buy Function Health: A Physician’s Perspective

Summary:

Many labs in large panels are already part of routine preventive care, but only a small number of additional tests have evidence to support screening in healthy, asymptomatic adults.

Broad, untargeted testing can cause harm through false positives, unnecessary follow‑up, anxiety, and care cascades—without improving long‑term health outcomes.

Effective prevention is about precision, not volume: ordering the right tests for the right person at the right time, guided by evidence and clinical context.

Read more >
blog post

When Is the Right Time to Consider Anti‑Aging Therapies?

Summary:

1. Aging pathways seem to help early and harm later — systems that drive growth and resilience in youth can fuel disease with age.

2. Timing may matter more than the drug — starting too early may backfire; most therapies make the most theoretical sense in midlife or later.

3. Personal biology and unique longevity goals come first — shared decision making about unproven gerotherapeutics should be individualized, not based on age alone.

Read more >